Switch theme
Sign up to access all valuation multiples
Ortoma AB is engaged in development of products and solutions for orthopedic and joint implant surgeries.
2001
5
Last FY Revenue $55.2M
Last FY EBITDA $0.7M
$32.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Ortoma achieved revenue of $55.2M and an EBITDA of $0.7M.
Ortoma expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Ortoma valuation multiples based on analyst estimates| NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|
| Revenue | XXX | $55.2M | XXX | XXX | XXX |
| Gross Profit | XXX | $55.0M | XXX | XXX | XXX |
| Gross Margin | XXX | 100% | XXX | XXX | XXX |
| EBITDA | XXX | $0.7M | XXX | XXX | XXX |
| EBITDA Margin | XXX | 1% | XXX | XXX | XXX |
| EBIT | XXX | -$16.4M | XXX | XXX | XXX |
| EBIT Margin | XXX | -30% | XXX | XXX | XXX |
| Net Profit | XXX | -$13.1M | XXX | XXX | XXX |
| Net Margin | XXX | -24% | XXX | XXX | XXX |
| Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Ortoma's stock price is EUR 1 (or $1).
Ortoma has current market cap of EUR 30.1M (or $33.8M), and EV of EUR 28.5M (or $32.0M).
See Ortoma trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $32.0M | $33.8M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Ortoma has market cap of $33.8M and EV of $32.0M.
Ortoma's trades at 0.6x EV/Revenue multiple, and 48.4x EV/EBITDA.
Equity research analysts estimate Ortoma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Ortoma's P/E ratio is not available.
See valuation multiples for Ortoma and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $33.8M | XXX | $33.8M | XXX | XXX | XXX |
| EV (current) | $32.0M | XXX | $32.0M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 0.6x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 48.4x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | -2.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | -2.6x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -0.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOrtoma's revenue per employee in the last FY averaged $11.0M, while opex per employee averaged $14.3M for the same period.
Ortoma's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Ortoma's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Ortoma and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 1% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $11.0M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $14.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 129% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ortoma acquired XXX companies to date.
Last acquisition by Ortoma was XXXXXXXX, XXXXX XXXXX XXXXXX . Ortoma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Ortoma founded? | Ortoma was founded in 2001. |
| Where is Ortoma headquartered? | Ortoma is headquartered in Germany. |
| How many employees does Ortoma have? | As of today, Ortoma has 5 employees. |
| Is Ortoma publicy listed? | Yes, Ortoma is a public company listed on FRA. |
| What is the stock symbol of Ortoma? | Ortoma trades under 82Y ticker. |
| When did Ortoma go public? | Ortoma went public in 2021. |
| Who are competitors of Ortoma? | Similar companies to Ortoma include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Ortoma? | Ortoma's current market cap is $33.8M |
| Is Ortoma profitable? | Yes, Ortoma is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
